Atrial Fibrillation Concept

subject area of

• 14 Antithrombotic treatment of cerebrovascular disease  Academic Article
• 2004 Canadian Cardiovascular Society Consensus Conference: Atrial Fibrillation.  Conference Paper
• 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Academic Article
• 2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Academic Article
• 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants  Academic Article
• 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation  Academic Article
• 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants  Academic Article
• 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)  Academic Article
• 2021 CAEP Acute Atrial Fibrillation/Flutter Best Practices Checklist  Academic Article
• A Call for Randomized Trials of Oral Anticoagulation for Patients With Post-Operative Atrial Fibrillation  Academic Article
• A Hungry Thrombus  Academic Article
• A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation  Academic Article
• A Systematic Review of Randomized Trials Comparing Radiofrequency Ablation with Antiarrhythmic Medications in Patients with Atrial Fibrillation  Academic Article
• A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score  Academic Article
• A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study  Academic Article
• A comparison between monophasic and biphasic defibrillation for the cardioversion of persistent atrial fibrillation in patients with and without heart failure  Academic Article
• A comparison of four risk models for the prediction of cardiovascular complications in patients with a history of atrial fibrillation undergoing non‐cardiac surgery  Academic Article
• A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome  Academic Article
• A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system  Academic Article
• A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation  Academic Article
• A factor score reflecting cognitive functioning in patients from the Swiss Atrial Fibrillation Cohort Study (Swiss-AF)  Academic Article
• A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial  Academic Article
• A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation  Academic Article
• A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women  Academic Article
• A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study  Academic Article
• A randomized ablation-based atrial fibrillation rhythm control versus rate control trial in patients with heart failure and high burden atrial fibrillation: The RAFT-AF trial rationale and design  Academic Article
• A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643]  Academic Article
• ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT)  Academic Article
• Ablate and pace for patients with atrial fibrillation: a fragile option?  Academic Article
• Accuracy and clinical outcomes of CT image integration with Carto-Sound compared to electro-anatomical mapping for atrial fibrillation ablation: A randomized controlled study  Academic Article
• Active-Fixation Atrial Leads and the Risk of Atrial Fibrillation  Academic Article
• Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012  Academic Article
• Adherence to anticoagulant treatment with dabigatran in a real‐world setting  Academic Article
• Advances in Cardiac Electrophysiology  Academic Article
• Advances in treatment and management  Academic Article
• Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study  Academic Article
• After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy  Academic Article
• After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding  Academic Article
• Alcohol Consumption and Atrial Arrhythmia Recurrence After Atrial Fibrillation Ablation: A Systematic Review and Meta-analysis  Academic Article
• Alcohol Consumption and Risk of Atrial Fibrillation  Academic Article
• Alcohol Consumption and Risk of Atrial Fibrillation  Academic Article
• Alcohol Consumption and Risk of Incident Atrial Fibrillation in Women  Academic Article
• Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation  Academic Article
• Alcohol consumption and the risk of incident atrial fibrillation among people with cardiovascular disease  Academic Article
• Alcohol consumption, atrial fibrillation, and cardiovascular disease: finding the right balance  Academic Article
• Aligning Health Care Policy With Evidence-Based Medicine: The Case for Funding Direct Oral Anticoagulants in Atrial Fibrillation  Academic Article
• Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation  Academic Article
• Amiodarone for refractory atrial fibrillation  Academic Article
• Amiodarone to Prevent Recurrence of Atrial Fibrillation  Academic Article
• An individual patient-based meta-analysis of the effects of dronedarone in patients with atrial fibrillation  Academic Article
• Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation  Academic Article
• Analysis of Stroke in ATHENA: A Placebo-Controlled, Double-Blind, Parallel-Arm Trial to Assess the Efficacy of Dronedarone 400 mg BID for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients With Atrial Fibrillation/Atrial Flutter  Academic Article
• Analysis of Upper Gastrointestinal Adverse Events Among Patients Given Dabigatran in the RE-LY Trial  Academic Article
• Anatomical and electrical remodeling with incomplete left atrial appendage ligation: Results from the LAALA-AF registry  Academic Article
• Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE‐LY trial  Academic Article
• Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation  Academic Article
• Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy  Academic Article
• Another Dimension of Safety in the Prescription of Anticoagulants for Nonvalvular Atrial Fibrillation  Academic Article
• Another oral thrombin inhibitor for stroke prevention in atrial fibrillation?  Academic Article
• Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-response  Academic Article
• Antiarrhythmic efficacy of azimilide in patients with atrial fibrillation. Maintenance of sinus rhythm after conversion to sinus rhythm.  Academic Article
• Antiarrhythmic use from 1991 to 2007: Insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II)  Academic Article
• Anticoagulants in Patients with Atrial Fibrillation and End-Stage Renal Disease  Academic Article
• Anticoagulants in atrial fibrillation patients with chronic kidney disease  Academic Article
• Anticoagulation for Atrial Fibrillation: State of the Art and Recommendations for a Quickly Moving Target  Academic Article
• Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation and End-Stage Renal Disease—First, Do No Harm  Academic Article
• Anticoagulation for newly diagnosed atrial fibrillation and 90-day rates of stroke and bleeding  Academic Article
• Anticoagulation for patients with atrial fibrillation and risk factors for stroke  Academic Article
• Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery  Academic Article
• Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: Wide variability of perioperative bridging in Canada  Academic Article
• Anticoagulation therapy for patients with atrial fibrillation.  Academic Article
• Anticoagulation/platelet inhibition for atrial fibrillation  Academic Article
• Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks  Academic Article
• Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks  Academic Article
• Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials  Academic Article
• Antiplatelet therapy in prevention of cardio- and venous thromboembolic events  Academic Article
• Antiplatelet therapy in the management of atherothrombosis: recent clinical advances  Academic Article
• Antithrombotic Agents  Academic Article
• Antithrombotic Therapy After Acute Ischemic Stroke in Patients With Atrial Fibrillation  Academic Article
• Antithrombotic Therapy After Coronary Artery Stenting in Patients With Atrial Fibrillation  Academic Article
• Antithrombotic Therapy for Atrial Fibrillation  Academic Article
• Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention  Academic Article
• Antithrombotic Treatment at Onset of Stroke with Atrial Fibrillation, Functional Outcome, and Fatality: A Systematic Review and Meta-Analysis  Academic Article
• Antithrombotic Treatments for Stroke Prevention in Elderly Patients With Nonvalvular Atrial Fibrillation: Drugs and Doses  Academic Article
• Antithrombotic drug development for atrial fibrillation: Proceedings, Washington, DC, July 25-27, 2005  Academic Article
• Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands - The EXAMINE-AF study. A questionnaire survey  Academic Article
• Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves  Academic Article
• Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation  Academic Article
• Antithrombotic therapy in atrial fibrillation.  Academic Article
• Antithrombotic therapy in atrial fibrillation.  Academic Article
• Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme  Academic Article
• Aortic Stiffness in Lone Atrial Fibrillation: A Novel Risk Factor for Arrhythmia Recurrence  Academic Article
• Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned  Academic Article
• Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?—A Systematic Review  Academic Article
• Apixaban in Patients with Atrial Fibrillation  Academic Article
• Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial  Academic Article
• Approach to the new oral anticoagulants in family practice: part 1: comparing the options.  Academic Article
• Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.  Academic Article
• Appropriate Use of Antithrombotic Medication in Canadian Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Appropriate outcome measures in trials evaluating treatment of atrial fibrillation  Academic Article
• Are Factor Xa Inhibitors Efficacious for Ischemic Stroke Prevention in Patients Without Atrial Fibrillation? Evidence From Randomized Clinical Trials  Academic Article
• Are NSAIDs Double Trouble?  Academic Article
• Are There Patients With Acute Ischemic Stroke and Atrial Fibrillation That Benefit From Low Molecular Weight Heparin?  Academic Article
• Are We Ready for Mass Screening to Detect Atrial Fibrillation?  Academic Article
• Assessing the Impact of Censoring of Costs and Effects on Health-Care Decision-Making: an Example Using the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study  Academic Article
• Assessing the impact of dabigatran and warfarin on health-related quality of life: Results from an RE-LY sub-study  Academic Article
• Assessment of Anticoagulation Intensity and Management of Bleeding With Old and New Oral Anticoagulants  Academic Article
• Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta‐analysis of randomized controlled trials  Academic Article
• Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes  Academic Article
• Association Between Patient and Physician Sex and Physician-Estimated Stroke and Bleeding Risks in Atrial Fibrillation  Academic Article
• Association between ventricular repolarization parameters and cardiovascular death in patients of the SWISS-AF cohort  Academic Article
• Association of Diabetes With Atrial Fibrillation Phenotype and Cardiac and Neurological Comorbidities: Insights From the Swiss‐AF Study  Academic Article
• Association of Eligibility for a Sodium-Glucose Cotransporter 2 Inhibitor and Cardiovascular Events in Patients With Atrial Fibrillation  Academic Article
• Association of Oral Anticoagulation With Stroke in Atrial Fibrillation or Heart Failure  Academic Article
• Association of Proteinuria and Incident Atrial Fibrillation in Patients With Intact and Reduced Kidney Function  Academic Article
• Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock  Academic Article
• Association of atrial fibrillation with mortality and disability after ischemic stroke  Academic Article
• Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis  Academic Article
• Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study  Academic Article
• Association of psychosocial factors with all‐cause hospitalizations in patients with atrial fibrillation  Academic Article
• Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation  Academic Article
• Association of statin therapy and the risk of atrial fibrillation in patients with a permanent pacemaker  Academic Article
• Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation  Academic Article
• Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation  Academic Article
• Asymptomatic or “Silent” Atrial Fibrillation  Academic Article
• At What Age Does Stroke Risk Increase in Patients With Atrial Fibrillation? Does It Depend on Where You Live?  Academic Article
• Atrial Arrhythmias in Clinically Manifest Cardiac Sarcoidosis: Incidence, Burden, Predictors, and Outcomes  Academic Article
• Atrial Cardiopathy in the Absence of Atrial Fibrillation Increases Risk of Ischemic Stroke, Incident Atrial Fibrillation, and Mortality and Improves Stroke Risk Prediction  Academic Article
• Atrial Fibrillation Causing Syncope?  Academic Article
• Atrial Fibrillation and Cancer—Validation in the Real World—Reply  Academic Article
• Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration  Academic Article
• Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation  Academic Article
• Atrial Fibrillation and PCI — Do We Still Need Aspirin?  Academic Article
• Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic Dysfunction  Academic Article
• Atrial Fibrillation in Patients with Cryptogenic Stroke  Academic Article
• Atrial Pacing Periablation for Prevention of Paroxysmal Atrial Fibrillation  Academic Article
• Atrial Premature Beats Predict Atrial Fibrillation in Cryptogenic Stroke  Academic Article
• Atrial deformation: the key to maintenance of sinus rhythm in patients with atrial fibrillation?  Academic Article
• Atrial fibrillation after cardiac surgery: update on the evidence on the available prophylactic interventions.  Academic Article
• Atrial fibrillation and atrial flutter.  Academic Article
• Atrial fibrillation and stroke: chicken or egg? Does it really matter?  Academic Article
• Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke?  Academic Article
• Atrial fibrillation and stroke: who is low risk and what are we going to do about it?  Academic Article
• Atrial fibrillation and the diagnosis of cardioembolic stroke.  Academic Article
• Atrial fibrillation as an uncommon presentation in a large pleomorphic xanthoastrocytoma  Academic Article
• Atrial fibrillation detected initially during acute medical illness: A systematic review  Academic Article
• Atrial fibrillation for internists: current practice  Academic Article
• Atrial fibrillation in a primary care practice: prevalence and management  Academic Article
• Atrial fibrillation in elderly patients with implantable loop recorders for unexplained syncope  Academic Article
• Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation  Academic Article
• Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing  Academic Article
• Atrial fibrillation is associated with hematopoietic tissue activation and arterial inflammation  Academic Article
• Atrial fibrillation is associated with increased mortality: causation or association?  Academic Article
• Atrial fibrillation occurring transiently with stress  Academic Article
• Atrial fibrillation, moderate chronic kidney disease, and stroke prevention: new anticoagulants, new hope  Academic Article
• Atrial fibrillation: guiding lessons from epidemiology  Academic Article
• Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target.  Academic Article
• Atrial overdrive pacing in sleep apnoea: a meta-analysis  Academic Article
• Atrial overdrive pacing to prevent atrial fibrillation: Insights from ASSERT  Academic Article
• Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation  Academic Article
• Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation: data from the Euro Heart Survey  Academic Article
• Azimilide for the Treatment of Atrial Fibrillation, Atrial Flutter, and Paroxysmal Supraventricular Tachycardia: Results of a Randomized Trial and Insights on the Concordance of Symptoms and Recurrent Arrhythmias  Academic Article
• Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation  Academic Article
• Balancing the Risks and Benefits of Oral Anticoagulant Use in Patients With Postoperative Atrial Fibrillation  Academic Article
• Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range  Academic Article
• Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease  Academic Article
• Betrixaban (PRT054021): pharmacology, dose selection and clinical studies  Academic Article
• Betrixaban compared with warfarin in patients with atrial fibrillation: results of a phase 2, randomized, dose-ranging study (Explore-Xa)  Academic Article
• Biological Therapies for Atrial Fibrillation  Academic Article
• Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation  Academic Article
• Biomarkers associated with rhythm status after cardioversion in patients with atrial fibrillation  Academic Article
• Biomarkers of Inflammation and Risk of Hospitalization for Heart Failure in Patients With Atrial Fibrillation  Academic Article
• Birth Weight Is a Significant Risk Factor for Incident Atrial Fibrillation  Academic Article
• Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.  Academic Article
• Bivariate evaluation of thromboembolism and bleeding in clinical trials of anticoagulants in patients with atrial fibrillation  Academic Article
• Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin  Academic Article
• Bleeding Risk in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Systematic Review and Meta-Analysis  Academic Article
• Bleeding and ischaemic events after first bleed in anticoagulated atrial fibrillation patients: risk and timing  Academic Article
• Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry  Academic Article
• Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study  Academic Article
• Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation  Academic Article
• Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience  Academic Article
• Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design  Academic Article
• Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: A systematic review and meta analysis of randomized controlled trials  Academic Article
• Blood Pressure and Brain Lesions in Patients With Atrial Fibrillation  Academic Article
• Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies  Academic Article
• Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis  Academic Article
• Bone morphogenetic protein 10: a novel risk marker of ischaemic stroke in patients with atrial fibrillation  Academic Article
• Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study  Academic Article
• Bridging Anticoagulation in Patients with Atrial Fibrillation  Academic Article
• Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation  Academic Article
• Bridging therapy in patients on long‐term oral anticoagulants who require surgery: the Prospective Peri‐operative Enoxaparin Cohort Trial (PROSPECT)  Academic Article
• Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation  Academic Article
• Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype  Academic Article
• Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population  Academic Article
• C-reactive protein for prediction of atrial fibrillation recurrence after catheter ablation  Academic Article
• COVID-19 and AF  Academic Article
• Caffeine consumption and incident atrial fibrillation in women  Academic Article
• Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Catheter Ablation for Atrial Fibrillation/Atrial Flutter  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Etiology and Initial Investigations  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Implementing GRADE and Achieving Consensus  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Management of Recent-Onset Atrial Fibrillation and Flutter in the Emergency Department  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention and Treatment of Atrial Fibrillation Following Cardiac Surgery  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management  Academic Article
• Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Surgical Therapy  Academic Article
• Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Update 2020  Academic Article
• Canadian Trial of Physiological Pacing  Academic Article
• Canadian atrial fibrillation anticoaguiation (CAFA) study  Academic Article
• Canadian atrial fibrillation anticoagulation study: were the patients subsequently treated with warfarin? Canadian Atrial Fibrillation Anticoagulation Study Group.  Academic Article
• Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017  Academic Article
• Canakinumab After Electrical Cardioversion in Patients With Persistent Atrial Fibrillation  Academic Article
• Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation  Academic Article
• Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial  Academic Article
• Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation  Academic Article
• Cardiac Tamponade During Uninterrupted Oral Anticoagulant Therapy for Catheter Ablation for Atrial Fibrillation  Academic Article
• Cardiac autonomic function and cognitive performance in patients with atrial fibrillation  Academic Article
• Cardioembolic Stroke  Academic Article
• Cardiology residents' anticoagulation preferences for stroke prophylaxis in atrial fibrillation patients  Academic Article
• Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants  Academic Article
• Cardiovascular Outcomes According to Polypharmacy and Drug Adherence in Patients with Atrial Fibrillation on Long-Term Anticoagulation (from the RE-LY Trial)  Academic Article
• Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing  Academic Article
• Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial  Academic Article
• Care of Patients Receiving Long-Term Anticoagulant Therapy  Academic Article
• Case Report: Drug Interaction Between Tacrolimus and Amiodarone With QT Prolongation  Academic Article
• Catheter Ablation Compared With Drug Therapy for Atrial Fibrillation  Academic Article
• Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure  Academic Article
• Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF  Academic Article
• Causes of Death and Influencing Factors in Patients With Atrial Fibrillation  Academic Article
• Celivarone for Maintenance of Sinus Rhythm and Conversion of Atrial Fibrillation/Flutter  Academic Article
• Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation  Academic Article
• Changes in Renal Function in Patients With Atrial Fibrillation  Academic Article
• Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis  Academic Article
• Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry  Academic Article
• Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale  Academic Article
• Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials  Academic Article
• Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study  Academic Article
• Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1  Academic Article
• Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2  Academic Article
• Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference  Academic Article
• Circadian variation of paroxysmal atrial fibrillation  Academic Article
• Clinical Outcomes in Atrial Fibrillation Research  Academic Article
• Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials  Academic Article
• Clinical trials of new anticoagulants.  Academic Article
• Clinical trials, the renin angiotensin system and atrial fibrillation  Academic Article
• Clopidogrel plus aspirin in atrial fibrillation.  Academic Article
• Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial  Academic Article
• Cognitive Function and Anticoagulation Control in Patients With Atrial Fibrillation  Academic Article
• Colchicine for Prevention of Perioperative Atrial Fibrillation in patients undergoing lung resection surgery: a pilot randomized controlled study  Academic Article
• Combined Antiplatelet Therapy in Atrial Fibrillation:  Academic Article
• Combined Metabolomic and Proteomic Analysis of Human Atrial Fibrillation  Academic Article
• Comment on model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients  Academic Article
• Comorbid Atrial Fibrillation in Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage: Between a Rock and a Hard Place  Academic Article
• Comparative effectiveness and safety of direct acting oral anticoagulants in nonvalvular atrial fibrillation for stroke prevention: a systematic review and meta-analysis  Academic Article
• Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study  Academic Article
• Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol  Academic Article
• Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study  Academic Article
• Comparative effectiveness of catheter ablation strategies for rhythm control in patients with atrial fibrillation: a meta-analysis  Academic Article
• Comparing mortality in patients with atrial fibrillation who are receiving a direct‐acting oral anticoagulant or warfarin: a meta‐analysis of randomized trials  Academic Article
• Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin  Academic Article
• Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)  Academic Article
• Comparison of Dabigatran and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease  Academic Article
• Comparison of Frequency of Ischemic Stroke in Patients With Versus Without Coronary Heart Disease and Without Atrial Fibrillation  Academic Article
• Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: Rationale and design of the OPTION randomized trial  Academic Article
• Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial  Academic Article
• Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial  Academic Article
• Comparison of health-related quality of life in patients with atrial fibrillation treated with catheter ablation or antiarrhythmic drug therapy: a systematic review and meta-analysis protocol  Academic Article
• Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists  Academic Article
• Comparison of the ecarin chromogenic assay and diluted thrombin time for quantification of dabigatran concentrations  Academic Article
• Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials  Academic Article
• Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials  Academic Article
• Comprehensive upstream treatment for atrial fibrillation, when and how?  Academic Article
• Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation  Academic Article
• Concomitant Surgical Left Atrial Appendage Occlusion: a Review  Academic Article
• Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial  Academic Article
• Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting  Academic Article
• Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration  Academic Article
• Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration  Academic Article
• Contemporary Utilization of Digoxin in Patients with Atrial Fibrillation  Academic Article
• Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)  Academic Article
• Conventional versus 3-D Echocardiography to Predict Arrhythmia Recurrence After Atrial Fibrillation Ablation  Academic Article
• Coronary artery disease affecting the atrial branches is an independent determinant of atrial fibrillation after myocardial infarction  Academic Article
• Cost effectiveness of LAA closure in patients with AF and contraindications to warfarin: comment  Academic Article
• Cost-Effectiveness of Dronedarone in Patients With Atrial Fibrillation in the ATHENA Trial  Academic Article
• Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation  Academic Article
• Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist  Academic Article
• Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation  Academic Article
• Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective  Academic Article
• Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation  Academic Article
• Costs of surgical ablation of atrial fibrillation in Ontario, Canada from 2006 to 2017  Academic Article
• Cryptogenic Stroke and Atrial Fibrillation  Academic Article
• D-dimer and factor VIIa in atrial fibrillation – prognostic values for cardiovascular events and effects of anticoagulation therapy  Academic Article
• Dabigatran Etexilate: Future Directions in Anticoagulant Treatment  Academic Article
• Dabigatran Versus Warfarin  Academic Article
• Dabigatran Versus Warfarin in Patients With Atrial Fibrillation  Academic Article
• Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation  Academic Article
• Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient management  Academic Article
• Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial  Academic Article
• Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE‐LY trial  Academic Article
• Dabigatran efficacy‐safety assessment for stroke prevention in patients with atrial fibrillation  Academic Article
• Dabigatran for stroke prevention in atrial fibrillation: the RE-LY trial  Academic Article
• Dabigatran in Patients with Mechanical Heart Valves  Academic Article
• Dabigatran in clinical practice: Contemporary overview of the evidence  Academic Article
• Dabigatran versus Warfarin in Patients with Atrial Fibrillation  Academic Article
• Dabigatran versus Warfarin in Patients with Mechanical Heart Valves  Academic Article
• Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada  Academic Article
• Dabigatran versus warfarin in patients with mechanical heart valves: reply  Academic Article
• Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study  Academic Article
• Dabigatran-Induced Acute Hepatitis  Academic Article
• Dabigatran-related coagulopathy: when can we assume the effect has “worn off”?  Academic Article
• Dabigatran: ready for prime time?  Academic Article
• Defibrillation testing and clinical outcomes after implantable cardioverter–defibrillator implantation in patients in atrial fibrillation at the time of implant: An analysis from the SIMPLE trial  Academic Article
• Defibrillator discharges in a young patient: What is the underlying arrhythmia?  Academic Article
• Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTH  Academic Article
• Derivation and validation of predictors of oral anticoagulant-related adverse events in seniors transitioning from hospital to home  Academic Article
• Descriptive analysis of pharmacy services provided after community pharmacy screening  Academic Article
• Design and rationale of the atrial fibrillation occurring transiently with stress (AFOTS) follow-up cohort study  Academic Article
• Design and rationale of the atrial fibrillation occurring transiently with stress (AFOTS) incidence study  Academic Article
• Detection of atrial fibrillation in asymptomatic at-risk individuals  Academic Article
• Determinants of Left Atrial Volume in Patients with Atrial Fibrillation  Academic Article
• Determinants of physical fitness in males with systolic heart failure.  Academic Article
• Developing a Conversation Aid to Support Shared Decision Making: Reflections on Designing Anticoagulation Choice  Academic Article
• Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation  Academic Article
• Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group  Academic Article
• Device-Detected Atrial Fibrillation Before and After Hospitalisation for Noncardiac Surgery or Medical Illness: Insights From ASSERT  Academic Article
• Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis  Academic Article
• Device-detected atrial tachyarrhythmias: what do we know?  Academic Article
• Device-detected subclinical atrial tachyarrhythmias: definition, implications and management—an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)  Academic Article
• Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study Commentary: Varied preferences reflect the reality of clinical practice  Academic Article
• Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter‐Based Atrial Fibrillation Ablation: A Population‐Based Cohort Study From Ontario, Canada  Academic Article
• Differential Impact of Risk Factors in Blacks and Whites in the Development of Atrial Fibrillation: the Reasons for Geographic And Racial Differences in Stroke (REGARDS) Study  Academic Article
• Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry  Academic Article
• Digoxin prescribing for heart failure in elderly residents of long-term care facilities.  Academic Article
• Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding  Academic Article
• Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis  Academic Article
• Direct Oral Anticoagulants and Myocardial Infarction  Academic Article
• Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies  Academic Article
• Direct oral anticoagulants  Academic Article
• Direct-Acting Oral Anticoagulants  Academic Article
• Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry  Academic Article
• Do omega-3 fatty acids prevent atrial fibrillation after open heart surgery? A meta-analysis of randomized controlled trials.  Academic Article
• Does Sex Affect Anticoagulant Use for Stroke Prevention in Nonvalvular Atrial Fibrillation?  Academic Article
• Does Statin Therapy Decrease the Risk for Bleeding in Patients Who Are Receiving Warfarin?  Academic Article
• Does activated protein C resistance increase the risk of systemic embolism in non rheumatic atrial fibrillation?  Academic Article
• Does catheter ablation for atrial fibrillation increase or reduce neurological insult?  Academic Article
• Does rhythm or rate control strategy influence anticoagulant treatment in older patients with atrial fibrillation? Data from REPOSI  Academic Article
• Does tooth brushing protect from atrial fibrillation and heart failure?  Academic Article
• Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation  Academic Article
• Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: The β-Blocker Length Of Stay (BLOS) study  Academic Article
• Dronedarone for Atrial Fibrillation  Academic Article
• Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter  Academic Article
• Dronedarone in High-Risk Permanent Atrial Fibrillation  Academic Article
• Dronedarone in patients with congestive heart failure: insights from ATHENA  Academic Article
• Dual-Chamber Versus Ventricular Pacing  Academic Article
• Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial  Academic Article
• Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT  Academic Article
• Duty-cycled bipolar/unipolar radiofrequency ablation for symptomatic atrial fibrillation induces significant pulmonary vein narrowing at long-term follow-up  Academic Article
• Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference  Academic Article
• Early Life Risk Factors for Incident Atrial Fibrillation in the Helsinki Birth Cohort Study  Academic Article
• Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation  Academic Article
• Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference  Academic Article
• Echo-Guided Pericardiocentesis  Academic Article
• Echocardiographic Predictors of Stroke in Patients With Atrial Fibrillation  Academic Article
• Edoxaban and amiodarone: interactions on multiple levels  Academic Article
• Edoxaban versus Warfarin in Patients with Atrial Fibrillation  Academic Article
• Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial  Academic Article
• Effect of PON1 Q192R Genetic Polymorphism on Clopidogrel Efficacy and Cardiovascular Events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events Trial and the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events  Academic Article
• Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation  Academic Article
• Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation  Academic Article
• Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold  Academic Article
• Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect  Academic Article
• Effect of Atrial Fibrillation on Atrial Thrombogenesis in Humans: Impact of Rate and Rhythm  Academic Article
• Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation  Academic Article
• Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation  Academic Article
• Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation  Academic Article
• Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study  Academic Article
• Effect of dronedarone on clinical end points in patients with atrial fibrillation and coronary heart disease: insights from the ATHENA trial  Academic Article
• Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi‐database cohort study with meta‐analysis  Academic Article
• Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min  Academic Article
• Effectiveness and safety of rivaroxaban vs. warfarin in non-valvular atrial fibrillation patients with a non-sex-related CHA2DS2-VASc score of 1  Academic Article
• Effectiveness of Amiodarone for Conversion of Atrial Fibrillation to Sinus Rhythm  Academic Article
• Effects of Azimilide on Heart Rate and ECG Conduction Intervals during Sinus Rhythm in Patients with a History of Atrial Fibrillation  Academic Article
• Effects of Dronedarone Started Rapidly After Amiodarone Discontinuation  Academic Article
• Effects of Dronedarone on Clinical Outcomes in Patients with Lone Atrial Fibrillation: Pooled Post Hoc Analysis from the ATHENA/EURIDIS/ADONIS Studies  Academic Article
• Effects of Physiologic Pacing versus Ventricular Pacing  Academic Article
• Effects of Physiologic Pacing versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular Causes  Academic Article
• Effects of Sinus Rhythm Maintenance on Left Heart Function After Electrical Cardioversion of Atrial Fibrillation: Implications for Tachycardia-Induced Cardiomyopathy  Academic Article
• Effects of dabigatran according to age in atrial fibrillation  Academic Article
• Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis  Academic Article
• Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment  Academic Article
• Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants  Academic Article
• Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation  Academic Article
• Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation  Academic Article
• Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial -  Academic Article
• Efficacy and Safety of Dronedarone in Patients Previously Treated With Other Antiarrhythmic Agents  Academic Article
• Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation  Academic Article
• Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial  Academic Article
• Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial  Academic Article
• Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial  Academic Article
• Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time—A RE-LY trial analysis  Academic Article
• Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study  Academic Article
• Efficacy of Azimilide for the Maintenance of Sinus Rhythm in Patients With Paroxysmal Atrial Fibrillation in the Presence and Absence of Structural Heart Disease  Academic Article
• Efficacy of Catheter Ablation for Nonparoxysmal Atrial Fibrillation  Academic Article
• Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation  Academic Article
• Efficacy of substituting innovator propafenone for its generic formulation in patients with atrial fibrillation  Academic Article
• Elevated Lipoprotein(a) and Risk of Atrial Fibrillation  Academic Article
• Epidemiology of atrial fibrillation  Academic Article
• Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: A systematic review and meta-regression  Conference Paper
• Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant—Reply  Academic Article
• Epigenetic Age and the Risk of Incident Atrial Fibrillation  Academic Article
• Establishing Therapeutic Equivalence of Complex Pharmaceuticals: The Case of Dabigatran  Academic Article
• Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke  Academic Article
• Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke: comment—Authors’ reply  Academic Article
• Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening: a multicountry patient-level meta-analysis of 141,220 screened individuals  Academic Article
• Ethnic Differences in Atrial Fibrillation Identified Using Implanted Cardiac Devices  Academic Article
• Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants  Academic Article
• Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.  Academic Article
• Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation  Academic Article
• Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials  Academic Article
• Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas  Academic Article
• Evaluation of therapeutic modalities in patients with life threatening arrhythmias.  Conference Paper
• Evidence-Based Analysis of Amiodarone Efficacy and Safety  Academic Article
• Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation  Academic Article
• Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial  Academic Article
• Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Factor Xa and thrombin as targets for new oral anticoagulants  Academic Article
• Factors Associated With the Epidemic of Hospitalizations Due to Atrial Fibrillation  Academic Article
• Factors Associated with Low Flow in Aortic Valve Stenosis  Academic Article
• Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards  Academic Article
• Factors determining utility measured with the EQ-5D in patients with atrial fibrillation  Academic Article
• Falling between the cracks: a case of amiodarone toxicity  Academic Article
• Fifty years of research on antithrombotic therapy: Achievements and disappointments  Academic Article
• Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control  Academic Article
• Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation  Conference Paper
• Frailty to predict unplanned hospitalization, stroke, bleeding, and death in atrial fibrillation  Conference Paper
• Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors  Academic Article
• GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation  Academic Article
• Gastroesophageal reflux and atrial fibrillation: is there any correlation?  Academic Article
• Gastrointestinal Bleeding With Edoxaban Versus Warfarin  Academic Article
• Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies  Academic Article
• Gender and left atrial appendage occlusion: Not the exception in cardiovascular procedures  Academic Article
• Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe  Academic Article
• Gene Expression Profiles for the Identification of Prevalent Atrial Fibrillation  Conference Paper
• Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium  Academic Article
• Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation  Academic Article
• Giant Left Atrial Myxoma and Associated Mitral Valve Pathology  Academic Article
• Global Prospective Safety Analysis of Rivaroxaban  Academic Article
• Global Survey of the Frequency of Atrial Fibrillation–Associated Stroke  Academic Article
• Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study  Academic Article
• Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals  Academic Article
• Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week  Academic Article
• Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial  Academic Article
• Guide to anticoagulant therapy. Part 2: Oral anticoagulants. American Heart Association.  Academic Article
• HIT complicating fondaparinux prophylaxis: fondaparinux-dependent platelet activation as a marker for fondaparinux- induced HIT  Academic Article
• Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation  Academic Article
• Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding  Academic Article
• Healthy lifestyle and prevention of atrial fibrillation: Weighty matters  Academic Article
• Heart Rate Variability Triangular Index as a Predictor of Cardiovascular Mortality in Patients With Atrial Fibrillation  Academic Article
• Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial  Academic Article
• Heart rate and adverse outcomes in patients with prevalent atrial fibrillation  Academic Article
• Hemorrhagic Complications of Anticoagulant Therapy  Academic Article
• Hemorrhagic Complications of Anticoagulant Treatment  Academic Article
• Hemorrhagic complications of long-term anticoagulant therapy.  Academic Article
• History of Atrial Fibrillation as a Risk Factor in Patients With Heart Failure and Preserved Ejection Fraction  Academic Article
• Home-monitoring of oral anticoagulation vs. dabigatran  Academic Article
• How Did We Get Here?: A Historical Review and Critical Analysis of Anticoagulation Therapy Following Mechanical Valve Replacement  Academic Article
• How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism  Academic Article
• How Should Results from Completed Studies Influence Ongoing Clinical Trials?  Academic Article
• How do family medicine residents choose an anticoagulation regimen for patients with nonvalvular atrial fibrillation?  Academic Article
• How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society  Academic Article
• How to evaluate antiarrhythmic agents in an essentially asymptomatic population.  Conference Paper
• How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators  Academic Article
• Human Study of Biatrial Electrical Coupling  Academic Article
• Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study  Academic Article
• ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part II – Management of Various Cardiovascular Complications  Academic Article
• Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study  Academic Article
• Identifying Patients With Atrial Fibrillation in Administrative Data  Academic Article
• Imaging for Atrial Fibrillation  Academic Article
• Impact of Left Atrial Appendage Exclusion on Cardiovascular Outcomes in Patients with Atrial Fibrillation Undergoing Coronary Artery Bypass Grafting (from the National Inpatient Sample Database)  Academic Article
• Impact of Modifiable Bleeding Risk Factors on Major Bleeding in Patients With Atrial Fibrillation Anticoagulated With Rivaroxaban  Academic Article
• Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial  Academic Article
• Impact of Switching From a Vitamin K Antagonist to Rivaroxaban on Satisfaction With Anticoagulation Therapy: The XANTUS-ACTS Substudy  Academic Article
• Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions  Academic Article
• Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada  Academic Article
• Impact of dronedarone on hospitalization burden in patients with atrial fibrillation: results from the ATHENA study  Academic Article
• Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect?  Academic Article
• Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry  Academic Article
• Impact of gender: Rivaroxaban for patients with atrial fibrillation in the XANTUS real‐world prospective study  Academic Article
• Impact of oral anticoagulation in patients with atrial fibrillation at very low thromboembolic risk  Academic Article
• Impact of ramipril on the incidence of atrial fibrillation: Results of the Heart Outcomes Prevention Evaluation study  Academic Article
• Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation  Academic Article
• Implantable loop recorders in patients with atrial fibrillation  Academic Article
• Implantable loop recorders in the real world: a study of two Canadian centers  Academic Article
• Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy  Academic Article
• Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation  Academic Article
• In AF, apixaban reduced stroke or systemic embolism compared with warfarin, regardless of patient age  Academic Article
• In anticoagulated patients with AF, HAS-BLED predicted major bleeding better than CHADS₂and CHA₂DS₂-VASc  Academic Article
• Incidence and Predictors of Atrial Fibrillation Progression  Academic Article
• Incidence and predictors of atrial fibrillation progression: A systematic review and meta-analysis  Academic Article
• Incidence and recurrence of new-onset atrial fibrillation detected during hospitalization for non-cardiac surgery: a systematic review and meta-analysis  Academic Article
• Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy  Academic Article
• Incident Atrial Fibrillation and Stroke in Patients With Atrial Flutter  Academic Article
• Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR  Academic Article
• Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study  Academic Article
• Incorporating edoxaban into the choice of anticoagulants for atrial fibrillation  Academic Article
• Increased burden of comorbidities and risk of cardiovascular death in atrial fibrillation patients in Europe over ten years: A comparison between EORP-AF pilot and EHS-AF registries  Academic Article
• Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies  Academic Article
• Independent predictors of stroke in patients with atrial fibrillation: A systematic review  Academic Article
• Indirect comparison: relative risk fallacies and odds solution  Academic Article
• Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale  Academic Article
• Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation  Academic Article
• Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women  Academic Article
• Influence of decision aids on patient preferences for anticoagulant therapy: a randomized trial  Academic Article
• Influence of leukotriene biosynthesis inhibition on heart rate in patients with atrial fibrillation  Academic Article
• Initiation of anticoagulation in atrial fibrillation by primary care physicians: Results of a telephone survey  Academic Article
• Insulin-like growth factor-binding protein 7 and risk of congestive heart failure hospitalization in patients with atrial fibrillation  Conference Paper
• Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): A cluster randomized trial of a computerized clinical decision support tool  Academic Article
• Integrating Clinical Decision Support into EMR and PHR: a Case Study Using Anticoagulation.  Academic Article
• Integrating Frailty Assessment Into Cardiovascular Decision Making  Academic Article
• Intensity and Quality of Warfarin Anticoagulation in Chinese Patients  Academic Article
• Interaction Between Digoxin and Dronedarone in the PALLAS Trial  Academic Article
• Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation  Academic Article
• International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)  Academic Article
• International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries  Academic Article
• Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery  Academic Article
• Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery  Academic Article
• Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis.  Academic Article
• Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: Preliminary meta-analysis of cohorts and anticoagulation decision schema  Academic Article
• Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran  Academic Article
• Intrapericardial Amiodarone for the Prevention of Postoperative Atrial Fibrillation  Academic Article
• Irbesartan in Patients with Atrial Fibrillation  Academic Article
• Is It Time to Systematically Replace Warfarin With a New Oral Anticoagulant for Higher-Risk Patients With Nonvalvular Atrial Fibrillation?  Academic Article
• Is New-Onset Postoperative AF a First Presentation of Paroxysmal AF?  Academic Article
• Is Screening for Atrial Fibrillation and Its Risk Factors Useful and Cost-Effective?  Academic Article
• Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?  Academic Article
• Is aspirin safer than a direct oral anticoagulant for patients with atrial fibrillation at high risk of bleeding?  Academic Article
• Is there a clinically significant seasonal component to hospital admissions for atrial fibrillation?  Academic Article
• Is there a role for pharmacokinetic/pharmacodynamic-guided dosing for novel oral anticoagulants?  Academic Article
• Is there a role for the novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials  Academic Article
• Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48  Academic Article
• Isolated transient aphasia at emergency presentation is associated with a high rate of cardioembolic embolism  Academic Article
• Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation  Academic Article
• LVS‐HARMED Risk Score for Incident Heart Failure in Patients With Atrial Fibrillation Who Present to the Emergency Department: Data from a World‐Wide Registry  Academic Article
• Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants  Academic Article
• Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation  Academic Article
• Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation  Academic Article
• Late Stroke After Coronary Artery Bypass Grafting  Academic Article
• Left Atrial Appendage Occlusion  Academic Article
• Left Atrial Appendage Occlusion Debate Revisited  Academic Article
• Left Atrial Appendage Occlusion Does Not Eliminate the Need for Warfarin  Academic Article
• Left Atrial Appendage Occlusion Eliminates the Need for Warfarin  Academic Article
• Left Atrial Appendage Occlusion Study (LAAOS): A randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention  Academic Article
• Left Atrial Appendage Occlusion Study (LAAOS): Results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke  Academic Article
• Left Atrial Appendage Occlusion Study II (LAAOS II)  Academic Article
• Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke  Academic Article
• Left Atrial Appendage Occlusion: A Narrative Review  Academic Article
• Left Atrial Enlargement Could Be Detected on Extended Computed Tomography Angiography Within Initial Stroke Assessment—Reply  Academic Article
• Left atrial anatomy, atrial fibrillation burden, and P-wave duration—relationships and predictors for single-procedure success after pulmonary vein isolation  Academic Article
• Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials  Academic Article
• Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis  Academic Article
• Left atrial volume and function in patients with atrial fibrillation  Academic Article
• Lessons learned from Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF): a pragmatic clinical trial of computerized decision support in primary care  Academic Article
• Letter by Belley-Côté and Whitlock Regarding Article, “Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery”  Academic Article
• Letter by Belley-Côté et al Regarding Article, “Randomized Controlled Trial of Surgical Versus Catheter Ablation for Paroxysmal and Early Persistent Atrial Fibrillation”  Academic Article
• Letter by Hess et al Regarding Article, “How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring”  Academic Article
• Letter by Ibrahim et al Regarding Article, “Anterior–Lateral Versus Anterior–Posterior Electrode Position for Cardioverting Atrial Fibrillation”  Academic Article
• Letter by de Vries et al Regarding Article “Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis”  Academic Article
• Letter to the Editor  Academic Article
• Life-threatening Ventricular Arrhythmias Provoked by Amiodarone Treatment  Academic Article
• Lifetime Pattern of Atrial Fibrillation and the Risks of Stroke and Death in a Population-based Cohort of Men (from The Manitoba Follow-Up Study)  Academic Article
• Limitations of Administrative Data for Examining Secondary Atrial Fibrillation  Academic Article
• Locations and Mucosal Lesions Responsible for Major Gastrointestinal Bleeding in Patients on Warfarin or Dabigatran  Academic Article
• Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROES  Academic Article
• Long-term Trends in Short-term Outcomes in Acute Myocardial Infarction  Academic Article
• Long-term amiodarone therapy and the risk of complications after cardiac surgery: Results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT)  Academic Article
• Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation  Academic Article
• Long-term comparison of cryoballoon and radiofrequency ablation of paroxysmal atrial fibrillation: A propensity score matched analysis  Academic Article
• Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation  Academic Article
• Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event  Academic Article
• Long-term risk of adverse outcomes according to atrial fibrillation type  Academic Article
• Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies  Academic Article
• Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin  Academic Article
• Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials  Academic Article
• Maintenance of Sinus Rhythm and Survival in Patients With Heart Failure and Atrial Fibrillation  Academic Article
• Major Adverse Cardiovascular Events Associated With Postoperative Atrial Fibrillation After Noncardiac Surgery  Academic Article
• Major Gastrointestinal Bleeding Often Is Caused by Occult Malignancy in Patients Receiving Warfarin or Dabigatran to Prevent Stroke and Systemic Embolism From Atrial Fibrillation  Academic Article
• Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry  Academic Article
• Management and Outcome of Acute Coronary Syndrome Patients in Relation to Prior History of Atrial Fibrillation  Academic Article
• Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin  Academic Article
• Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor  Academic Article
• Management of Anticoagulation Around Pacemaker and Defibrillator Surgery  Academic Article
• Management of a Left Atrial Appendage Thrombus Due to Atrial Fibrillation Complicating Québec Platelet Disorder  Academic Article
• Management of acute atrial fibrillation in the intensive care unit: An international survey  Academic Article
• Management of antithrombotic therapy after gastrointestinal bleeding: A mixed methods study of health‐care providers  Academic Article
• Management of atrial high-rate episodes detected by cardiac implanted electronic devices  Academic Article
• Management of bleeding with oral anticoagulants in patients with atrial fibrillation  Academic Article
• Managing Novel Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Device Surgery: Canadian Survey  Academic Article
• Mechanical left atrial appendage closure was noninferior and superior to warfarin in atrial fibrillation  Academic Article
• Mechanism of Action and Pharmacology of Unfractionated Heparin  Academic Article
• Mechanisms and Clinical Manifestations of Cognitive Decline in Atrial Fibrillation Patients: Potential Implications for Preventing Dementia  Academic Article
• Meeting the Unmet Needs in Anticoagulant Therapy  Academic Article
• Menopausal age, postmenopausal hormone therapy and incident atrial fibrillation  Academic Article
• Meta-Analysis of Surgical Left Atrial Appendage Occlusion During Cardiac Surgery  Academic Article
• Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation  Academic Article
• Metoprolol prophylaxis against postoperative atrial fibrillation increases length of hospital stay in patients not on pre-operative   blockers: the   blocker length of stay (BLOS) trial  Academic Article
• Mobile health applications for the detection of atrial fibrillation: a systematic review  Academic Article
• Modification of Outcomes With Aspirin or Apixaban in Relation to CHADS ₂ and CHA ₂ DS ₂ -VASc Scores in Patients With Atrial Fibrillation  Academic Article
• Modification of Outcomes With Aspirin or Apixaban in Relation to Female and Male Sex in Patients With Atrial Fibrillation  Academic Article
• Monitoring and management of patients with chronic atrial fibrillation: Is there added value in the identification of clinical phenotypes?  Academic Article
• Monitoring the ACTIVE-W trial: Some issues in monitoring a noninferiority trial  Academic Article
• Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials  Academic Article
• Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W  Academic Article
• Multi-ethnic genome-wide association study for atrial fibrillation  Academic Article
• Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation  Academic Article
• Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial  Academic Article
• NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank  Academic Article
• NOACs only for those who cannot tolerate a VKA: where is the evidence?  Academic Article
• Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable  Academic Article
• New Anticoagulants for Atrial Fibrillation  Academic Article
• New Anticoagulants for Atrial Fibrillation: The Beginning of a A New Era in Stroke Prevention  Academic Article
• New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes  Academic Article
• New anticoagulants in atrial fibrillation management  Conference Paper
• New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF  Academic Article
• New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions  Academic Article
• New oral anticoagulants in atrial fibrillation  Academic Article
• New oral anticoagulants in development  Academic Article
• New oral anticoagulants in elderly patients  Academic Article
• New pharmacotherapy for stroke prevention in atrial fibrillation: Update 2010  Academic Article
• New-Onset Atrial Fibrillation  Academic Article
• New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement  Academic Article
• New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults—a multicenter retrospective cohort study  Academic Article
• New-onset atrial fibrillation in adult critically ill patients: a scoping review  Academic Article
• New-onset perioperative atrial fibrillation in cardiac surgery patients: transient trouble or persistent problem?  Academic Article
• Newly Identified Events in the RE-LY Trial  Academic Article
• New‐Onset Perioperative Atrial Fibrillation After Coronary Artery Bypass Grafting and Long‐Term Risk of Adverse Events: An Analysis From the CORONARY Trial  Academic Article
• New‐onset atrial fibrillation in the intensive care unit: Protocol for an international inception cohort study (AFIB‐ICU)  Academic Article
• New‐onset atrial fibrillation in the medical intensive care unit: Catch me if you can  Academic Article
• Noninvasive Cardiac Monitoring for Detecting Paroxysmal Atrial Fibrillation or Flutter After Acute Ischemic Stroke  Academic Article
• Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.  Academic Article
• Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study  Academic Article
• North American Thrombosis Forum, AF Action Initiative Consensus Document  Academic Article
• Novel Oral Anticoagulants for Atrial Fibrillation  Academic Article
• Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism  Academic Article
• Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.  Academic Article
• Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulants  Academic Article
• Novel oral anticoagulants in gastroenterology practice  Academic Article
• Novel oral anticoagulants in secondary prevention of stroke  Academic Article
• Number of Pregnancies and Atrial Fibrillation Risk  Academic Article
• Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study  Academic Article
• Optimizing chronic disease management in the community (outpatient) setting (OCDM): an evidentiary framework.  Academic Article
• Optimizing primary care management of atrial fibrillation: The rationale and methods of the Integrated Management Program Advancing Community Treatment of Atrial Fibrillation (IMPACT-AF) study  Academic Article
• Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Cancer  Academic Article
• Oral Anticoagulant Use in Patients with Morbid Obesity: A Systematic Review and Meta-Analysis  Academic Article
• Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation  Academic Article
• Oral Anticoagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry*  Academic Article
• Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts  Academic Article
• Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF  Academic Article
• Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks  Academic Article
• Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks  Academic Article
• Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks  Academic Article
• Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range.  Academic Article
• Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis  Academic Article
• Orally Active Direct Thrombin Inhibitors  Academic Article
• Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials  Academic Article
• Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation  Academic Article
• Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study  Academic Article
• Outcomes and predictors of very stable INR control during chronic anticoagulation therapy  Academic Article
• Outcomes associated with non-recommended dosing of rivaroxaban: results from the XANTUS study  Academic Article
• Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF  Academic Article
• Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Overview of the New Oral Anticoagulants  Academic Article
• Pacemaker-Detected Atrial Fibrillation in Patients With Pacemakers: Prevalence, Predictors, and Current Use of Oral Anticoagulation  Academic Article
• Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)  Academic Article
• Paroxysmal Atrial Fibrillation in a Patient on Hemodialysis  Academic Article
• Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network meta-analysis incorporating complementary external evidence  Academic Article
• Patient outcomes using the European label for dabigatran  Academic Article
• Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines  Academic Article
• Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls  Academic Article
• Patients with Atrial Fibrillation Undergoing Cardiac Surgery: No Left Atrial Appendage Shall Remain Untouched  Academic Article
• Patient‐Reported Outcomes and Patient‐Reported Experience of Patients With Atrial Fibrillation in the IMPACT‐AF Clinical Trial  Academic Article
• Pattern of Atrial Fibrillation and Cognitive Function in Young Patients With Atrial Fibrillation and Low CHADS ₂ Score: Insights From the BRAIN-AF Trial  Academic Article
• Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation  Academic Article
• Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial  Academic Article
• Pericardial Fat Is Associated With Atrial Fibrillation Severity and Ablation Outcome  Academic Article
• Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack  Academic Article
• Perioperative Atrial Fibrillation and the Long-term Risk of Ischemic Stroke  Academic Article
• Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation  Academic Article
• Perioperative Management of Antithrombotic Therapy  Academic Article
• Perioperative anticoagulant management in patients with atrial fibrillation: practical implications of recent clinical trials  Academic Article
• Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.  Academic Article
• Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians  Academic Article
• Perioperative anticoagulation—are we at 'a bridge too far'?  Academic Article
• Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure  Academic Article
• Perioperative management of antithrombotic therapy: a case-based narrative review  Academic Article
• Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial  Academic Article
• Periprocedural Management and Approach to Bleeding in Patients Taking Dabigatran  Academic Article
• Periprocedural Management of New Oral Anticoagulants in Patients Undergoing Atrial Fibrillation Ablation  Academic Article
• Periprocedural Management of Oral Anticoagulation  Academic Article
• Periprocedural Management of Oral Anticoagulation in Patients With Atrial Fibrillation: Approach in the Era of New Oral Anticoagulants  Academic Article
• Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery  Academic Article
• Permanent Bilateral Carotid Filters for Stroke Prevention in Atrial Fibrillation  Academic Article
• Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation  Academic Article
• Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation  Academic Article
• Perspective and practice of surgical atrial fibrillation ablation: an international survey of cardiac surgeons  Academic Article
• Physical Activity and the Risk of Incident Atrial Fibrillation in Women  Academic Article
• Physical activity and brain health in patients with atrial fibrillation  Conference Paper
• Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.  Academic Article
• Plasma Apixaban Levels in Patients Treated Off Label With the Lower Dose  Academic Article
• Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial  Academic Article
• Population-Based Screening for Atrial Fibrillation  Academic Article
• Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: An analysis from ASSERT  Academic Article
• Postoperative atrial fibrillation after non-cardiac surgery: How important is it and what do we do about it?  Academic Article
• Postoperative atrial fibrillation in non‐cardiac and cardiac surgery: an overview  Academic Article
• Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial  Academic Article
• Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke  Academic Article
• Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation  Academic Article
• Practical aspects of new oral anticoagulant use in atrial fibrillation  Academic Article
• Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk  Academic Article
• Practical management of bleeding in patients receiving non-vitamin K antagonist oral anticoagulants  Academic Article
• Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation  Academic Article
• Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis  Academic Article
• Pre-Screening for Atrial Fibrillation Using the Electronic Health Record  Academic Article
• Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy  Academic Article
• Pre-treatment with antiarrhythmic drugs for elective electrical cardioversion of atrial fibrillation: a systematic review and network meta-analysis  Academic Article
• Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study  Academic Article
• Predicting in a predicament: Stroke and hemorrhage risk prediction in dialysis patients with atrial fibrillation  Academic Article
• Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol  Academic Article
• Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study  Academic Article
• Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A])  Academic Article
• Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF  Academic Article
• Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries  Academic Article
• Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial  Academic Article
• Predictors of preprocedural direct oral anticoagulant levels in patients having an elective surgery or procedure  Academic Article
• Predictors, Prognosis, and Management of New Clinically Important Atrial Fibrillation After Noncardiac Surgery: A Prospective Cohort Study  Academic Article
• Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making  Academic Article
• Preoperative levels of natriuretic peptides and the incidence of postoperative atrial fibrillation after noncardiac surgery: a prospective cohort study  Academic Article
• Prevalence and Management of Atrial Thrombi in Patients With Atrial Fibrillation Before Pulmonary Vein Isolation  Academic Article
• Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People  Academic Article
• Prevalence and risk of inappropriate dosing of direct oral anticoagulants in two Swiss atrial fibrillation registries  Academic Article
• Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation  Academic Article
• Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer  Academic Article
• Prevalence of risk factors for atrial fibrillation and stroke among 1210 patients with sleep disordered breathing  Academic Article
• Prevalence of undiagnosed atrial fibrillation in elderly individuals and potential cost-effectiveness of non-invasive ambulatory electrocardiographic screening: The ASSERT-III study  Academic Article
• Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran  Academic Article
• Preventing and managing bleeding complications in anticoagulated patients: A case based approach  Academic Article
• Preventing stroke in atrial fibrillation: why are so many eligible patients not receiving anticoagulant therapy?  Academic Article
• Preventing stroke in patients with atrial fibrillation: Current treatments and new concepts  Academic Article
• Prevention of Atrial Fibrillation  Academic Article
• Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers  Academic Article
• Prevention of Vascular Events in Patients with Atrial Fibrillation:  Academic Article
• Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program  Academic Article
• Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program.  Academic Article
• Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation  Academic Article
• Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke  Academic Article
• Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry  Academic Article
• Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation”  Academic Article
• Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation  Academic Article
• Prognostic Usefulness of Left Ventricular Hypertrophy by Electrocardiography in Patients With Atrial Fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study)  Academic Article
• Prognostic differences between atrial fibrillation and atrial flutter  Academic Article
• Prognostic significance of present atrial fibrillation on a single office electrocardiogram in patients with atrial fibrillation  Academic Article
• Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9–10, 2013  Academic Article
• Progression From Paroxysmal to Persistent Atrial Fibrillation  Academic Article
• Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure  Academic Article
• Progression of paroxysmal to persistent atrial fibrillation: 10-year follow-up in the Canadian Registry of Atrial Fibrillation  Academic Article
• Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing  Academic Article
• Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: Results from the Canadian Registry of Atrial Fibrillation  Academic Article
• Prolonged Cardiac Monitoring and Stroke Recurrence  Academic Article
• Promoting the health of senior citizens.  Academic Article
• Prospective Assessment of Sex‐Related Differences in Symptom Status and Health Perception Among Patients With Atrial Fibrillation  Academic Article
• Protocol for a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Trials of Screening for Atrial Fibrillation to Prevent Stroke  Academic Article
• QTc interval, cardiovascular events and mortality in patients with atrial fibrillation  Academic Article
• Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry  Academic Article
• Quality of individual INR control and the risk of stroke and bleeding events in atrial fibrillation patients: A nested case control analysis of the ACTIVE W study  Academic Article
• Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation  Academic Article
• Quantification of mitochondrial sublimons in human fibrillating atria  Academic Article
• RAFF-3 Trial: A Stepped-Wedge Cluster Randomised Trial to Improve Care of Acute Atrial Fibrillation and Flutter in the Emergency Department  Academic Article
• RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT  Academic Article
• Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2)  Academic Article
• Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation  Academic Article
• Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial  Academic Article
• Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation  Academic Article
• Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. The atrial pacing peri-ablation for paroxysmal atrial fibrillation (PA (3)) study investigators.  Academic Article
• Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation  Academic Article
• Rates of Ischemic Stroke During Warfarin Treatment for Atrial Fibrillation  Academic Article
• Rates of hemorrhage during warfarin therapy for atrial fibrillation  Academic Article
• Rationale and Design of ATHENA: A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in PatiENts with Atrial Fibrillation/Atrial Flutter  Academic Article
• Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events  Academic Article
• Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment  Academic Article
• Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran  Academic Article
• Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial  Academic Article
• Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial  Academic Article
• Rationale, Design, and the Baseline Characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study†  Academic Article
• Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702.  Academic Article
• Real-world experience with atrial fibrillation ablation: cause for concern  Academic Article
• Real-world variability in dabigatran levels in patients with atrial fibrillation: reply  Academic Article
• Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS  Academic Article
• Real‐world variability in dabigatran levels in patients with atrial fibrillation  Academic Article
• Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial  Academic Article
• Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation  Academic Article
• Reducing the risk of recurrent stroke in patients with AF  Academic Article
• Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta-analysis  Academic Article
• Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach  Academic Article
• Relation of Atrial Fibrillation and Right-Sided Cardiac Thrombus to Outcomes in Patients With Acute Pulmonary Embolism  Academic Article
• Relation of Renal Function to Risk for Incident Atrial Fibrillation in Women  Academic Article
• Relationship Between Degree of Left Ventricular Dysfunction, Symptom Status, and Risk of Embolic Events in Patients With Atrial Fibrillation and Heart Failure  Academic Article
• Relationship Between Psychosocial Stressors and Atrial Fibrillation in Women >45 Years of Age  Academic Article
• Relationship between QRS duration and incident atrial fibrillation  Academic Article
• Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve)  Academic Article
• Relationships of Measured and Genetically Determined Height With the Cardiac Conduction System in Healthy Adults  Academic Article
• Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation  Academic Article
• Relevance of Electrical Remodeling in Human Atrial Fibrillation  Academic Article
• Reply  Academic Article
• Reply  Academic Article
• Reply  Academic Article
• Reply to Left Atrial Appendage Closure During Cardiac Surgery for Atrial Fibrillation: A Meta-Analysis  Academic Article
• Reply to Saka et al.—Rhythm Control and Dementia in Patients With Atrial Fibrillation: A Role for Glymphatic System?  Academic Article
• Reply to Sex Differences in the Clinical Outcomes After Left Atrial Appendage: A Systematic Review and Meta-Analysis  Academic Article
• Reply to Xu—Oral Anticoagulants, Health Technology Assessment, and Health Policy  Academic Article
• Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation  Conference Paper
• Research Priorities in Atrial Fibrillation Screening  Academic Article
• Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Response by Parkash et al to Letters Regarding Article, “Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])”  Academic Article
• Response to Letter Regarding Article “Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events”  Academic Article
• Response to Letter Regarding Article, “Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy”  Academic Article
• Response to Letter Regarding Article, “Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study”  Academic Article
• Response to Letter Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis”  Academic Article
• Response to Letter Regarding Article, “Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin”  Academic Article
• Response to “Electrocardiographic sexual differences in patients with atrial fibrillation”  Academic Article
• Restarting antithrombotics after GI bleeding was linked to better outcomes in patients with AF  Academic Article
• Resuming warfarin after intracranial hemorrhage in patients with AF was linked to reduced mortality  Academic Article
• Reversal of Direct Oral Anticoagulants: Current Status and Future Directions  Academic Article
• Reversal of Warfarin  Academic Article
• Reversal of dabigatran-associated major bleeding with activated prothrombin concentrate: A prospective cohort study  Academic Article
• Reverse atrial electrical remodelling following atrial defibrillation as determined by signal-averaged ECG.  Academic Article
• Review: In renal impairment, apixaban reduces, or does not increase, bleeding compared with other anticoagulants  Academic Article
• Review: Novel oral anticoagulants reduce stroke more than ASA in nonvalvular atrial fibrillation  Academic Article
• Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure  Academic Article
• Rhythm- and Rate-Controlling Effects of Dronedarone in Patients With Atrial Fibrillation (from the ATHENA Trial)  Academic Article
• Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry  Academic Article
• Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit)  Academic Article
• Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation  Academic Article
• Risk factors for heart failure hospitalizations among patients with atrial fibrillation  Academic Article
• Risk factors for incident atrial fibrillation with and without left atrial enlargement in women  Academic Article
• Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study  Academic Article
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials  Academic Article
• Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation  Academic Article
• Risk of Death and Cardiovascular Events in Initially Healthy Women With New-Onset Atrial Fibrillation  Academic Article
• Risk of Haemorrhage Associated with Long Term Anticoagulant Therapy  Academic Article
• Risk of Hospital Admissions in Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis  Academic Article
• Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation  Academic Article
• Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation  Academic Article
• Risk of intracranial hemorrhage between different direct oral anticoagulants in older patients seen in the emergency department with a head injury: A population-based cohort study  Academic Article
• Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES  Academic Article
• Risk of mortality and stroke after atrial fibrillation – Authors' reply  Academic Article
• Risk of stroke after surgery in patients with and without chronic atrial fibrillation  Academic Article
• Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery  Academic Article
• Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials  Academic Article
• Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry  Academic Article
• Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular disease  Academic Article
• Risks and Benefits of Anticoagulant Therapy  Academic Article
• Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk  Academic Article
• Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials  Academic Article
• Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry  Academic Article
• Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial  Academic Article
• Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial  Academic Article
• Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation  Academic Article
• Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation  Academic Article
• Role of antithrombotic therapy in atrial fibrillation.  Academic Article
• Role of oral anticoagulation in management of atrial fibrillation  Academic Article
• Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling.  Academic Article
• Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents  Academic Article
• ST segment depression on 24-hour electrocardiography predicts incident atrial fibrillation in two population-based cohorts  Academic Article
• Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis  Academic Article
• Safety of Urgent Cardioversion for Patients With Recent-Onset Atrial Fibrillation and Flutter  Academic Article
• Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study  Academic Article
• Screening for Atrial Fibrillation  Academic Article
• Screening for Atrial Fibrillation Using a Mobile, Single-Lead Electrocardiogram in Canadian Primary Care Clinics  Academic Article
• Screening for Atrial Fibrillation in the Older Population  Academic Article
• Screening for undiagnosed atrial fibrillation  Academic Article
• Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation  Academic Article
• Searching for Atrial Fibrillation Poststroke  Academic Article
• Serial measurement of interleukin‐6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE‐LY trials  Academic Article
• Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment  Academic Article
• Sex differences of vascular brain lesions in patients with atrial fibrillation  Academic Article
• Sex-related electrocardiographic differences in patients with different types of atrial fibrillation: Results from the SWISS-AF study  Academic Article
• Sex-specific differences in adverse outcome events among patients with atrial fibrillation  Academic Article
• Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen?  Academic Article
• Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial  Academic Article
• Should Patients With Ischemic Stroke or Transient Ischemic Attack With Atrial Fibrillation and Microbleeds Be Anticoagulated?  Academic Article
• Should patients with advanced chronic kidney disease and atrial fibrillation receive chronic anticoagulation?  Academic Article
• Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?  Academic Article
• Silent brain infarcts impact on cognitive function in atrial fibrillation  Academic Article
• Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation  Academic Article
• Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of Warfarin  Academic Article
• Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials  Academic Article
• Sinus rhythm: thesine qua nonfor rhythm control?  Academic Article
• Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: A population-based study  Academic Article
• Sodium‐Glucose Co‐Transporter Inhibitors and Atrial Fibrillation: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials  Academic Article
• Sotalol Infusion in the Treatment of Supraventricular Tachyarrhythmias  Academic Article
• Strategies for the prevention and treatment of bleeding in patients treated with dabigatran: an update  Academic Article
• Stroke Prevention in Atrial Fibrillation  Academic Article
• Stroke Prevention in Atrial Fibrillation  Academic Article
• Stroke Prevention in Atrial Fibrillation II Study  Academic Article
• Stroke Prevention in Atrial Fibrillation II Study.  Academic Article
• Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease  Academic Article
• Stroke Prevention in Nonvalvular Atrial Fibrillation  Academic Article
• Stroke Risk and Efficacy of Apixaban in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease  Academic Article
• Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey  Academic Article
• Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?  Academic Article
• Stroke prevention for patients with atrial fibrillation: values and preferences of Canadian emergency medicine trainees  Academic Article
• Stroke prevention in AF: Of Asians and non-Asians  Academic Article
• Stroke prevention in atrial fibrillation: Closing the gap  Academic Article
• Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes  Academic Article
• Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation  Academic Article
• Stroke prevention in older adults with atrial fibrillation  Academic Article
• Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry  Academic Article
• Stroke prevention in patients with atrial fibrillation: The diagnosis and management of hypertension by specialists  Academic Article
• Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease  Academic Article
• Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT)  Academic Article
• Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program  Academic Article
• Structure and function of a perioperative anticoagulation management clinic  Academic Article
• Subclinical Atrial Fibrillation and the Risk of Stroke  Academic Article
• Subclinical Atrial Fibrillation in Older Patients  Academic Article
• Subclinical atrial fibrillation: The significance of progression to longer episodes  Academic Article
• Subclinical thyroid function and cardiovascular events in patients with atrial fibrillation  Academic Article
• Surgical ablation of atrial fibrillation: a protocol for a systematic review and meta-analysis of randomised controlled trials  Academic Article
• Surgical ablation of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials  Academic Article
• Switching Patients From Blinded Study Drug to Warfarin at the End of the ENGAGE AF–TIMI 48 Trial  Academic Article
• Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart Survey  Academic Article
• Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials  Academic Article
• Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease  Academic Article
• Systematic Review of Observational Studies Assessing Bleeding Risk in Patients with Atrial Fibrillation Not Using Anticoagulants  Academic Article
• Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis  Academic Article
• Techniques improving electrical cardioversion success for patients with atrial fibrillation: a systematic review and meta-analysis  Academic Article
• Temporal Association of Atrial Fibrillation With Cardiac Implanted Electronic Device Detected Heart Failure Status  Academic Article
• Temporal Patterns and Predictors of Rate vs Rhythm Control in Patients Attending a Multidisciplinary Atrial Fibrillation Clinic  Academic Article
• Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events  Academic Article
• The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation  Academic Article
• The Burden of Atrial Fibrillation on the Hospital Sector in Canada  Academic Article
• The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy  Academic Article
• The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?  Academic Article
• The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C-CUSP ED)  Academic Article
• The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2  Academic Article
• The Cost of Clopidogrel Use in Atrial Fibrillation in the ACTIVE-A Trial  Academic Article
• The Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation  Academic Article
• The Dx-AF study: a prospective, multicenter, randomized controlled trial comparing VDD-ICD to VVI-ICD in detecting sub-clinical atrial fibrillation in defibrillator patients  Academic Article
• The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients  Academic Article
• The Evolving Role of Stroke Prediction Schemes for Patients With Atrial Fibrillation  Academic Article
• The Guideline-Policy Gap in Direct-Acting Oral Anticoagulants Usage in Atrial Fibrillation: Evidence, Practice, and Public Policy Considerations  Academic Article
• The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation  Academic Article
• The Increasing Burden of Atrial Fibrillation Compared With Heart Failure and Myocardial Infarction: A 15-Year Study of All Hospitalizations in Australia  Academic Article
• The King is Dead (Warfarin): Direct Thrombin and Factor Xa Inhibitors: The Next Diadochian War?  Academic Article
• The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation  Academic Article
• The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study  Academic Article
• The New Canadian Cardiovascular Society Algorithm for Antithrombotic Therapy of Atrial Fibrillation Is Appropriately Based on Current Epidemiologic Data  Academic Article
• The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations  Academic Article
• The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial Fibrillation  Academic Article
• The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial  Academic Article
• The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale  Academic Article
• The RACE to Treat Atrial Fibrillation in the Emergency Department  Academic Article
• The Risk Factors for Thromboembolism in Nonvalvular Atrial Fibrillation and CHADS2 Scoring in Japan  Academic Article
• The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation  Academic Article
• The anticoagulation choices of internal medicine residents for stroke prevention in non-valvular atrial fibrillation  Academic Article
• The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events  Academic Article
• The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation  Academic Article
• The association of left atrial size and occurrence of atrial fibrillation: A prospective cohort study from the Canadian Registry of Atrial Fibrillation  Academic Article
• The canadian registry of atrial fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation  Academic Article
• The conundrum of resuming anticoagulant therapy after intracerebral bleeding: In whom, when, and how?  Academic Article
• The cost‐effectiveness of computer‐assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre study  Academic Article
• The detection and treatment of subclinical atrial fibrillation: evaluating the IMPACT of a comprehensive strategy based on remote arrhythmia monitoring  Academic Article
• The development of an Assessment and Intervention Falls Guide for older hospitalized adults with cardiac conditions  Academic Article
• The effect of colchicine administration on postoperative pleural effusion following lung resection: a randomized blinded placebo-controlled feasibility pilot study†  Academic Article
• The effects of apixaban on hospitalizations in patients with different types of atrial fibrillation: insights from the AVERROES trial  Academic Article
• The hazards of interrupting anticoagulation therapy in atrial fibrillation  Academic Article
• The heart-brain connection: further establishing the relationship between atrial fibrillation and dementia?  Academic Article
• The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey  Academic Article
• The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians  Academic Article
• The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study  Academic Article
• The prediction of postoperative stroke or death in patients with preoperative atrial fibrillation undergoing non‐cardiac surgery: a VISION sub‐study  Academic Article
• The quest for indicators of paroxysmal atrial fibrillation in sinus rhythm – the DETECT AF trial  Academic Article
• The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation.  Academic Article
• The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis  Academic Article
• The role of brain natriuretic peptide in atrial fibrillation: a substudy of the Substrate Modification with Aggressive Blood Pressure Control for Atrial Fibrillation (SMAC-AF) trial  Academic Article
• The signal averaged P wave in atrioventricular block—evidence for abnormal atrial conduction?  Academic Article
• The significance of new onset atrial fibrillation complicating acute myocardial infarction  Academic Article
• The value of cardiovascular hospitalization as an endpoint for clinical atrial fibrillation research  Academic Article
• The value of novel oral anticoagulants in rural Australia  Academic Article
• The winding path towards rationale anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation  Academic Article
• Therapies for the prevention of stroke and other vascular events in atrial fibrillation and atrial flutter.  Academic Article
• Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared With Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation  Academic Article
• Thoracoscopic Left Atrial Appendage Occlusion  Academic Article
• Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials  Academic Article
• Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. The Clinical Quality Improvement Network (CQIN) Investigators.  Academic Article
• Thyroid replacement therapy and atrial fibrillation in acute ischemic stroke  Academic Article
• Time in therapeutic range: Warfarin anticoagulation for atrial fibrillation in a community-based practice.  Academic Article
• To the Editor— Device enabled left atrial appendage ligation—A word of caution  Academic Article
• Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation  Academic Article
• Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.  Academic Article
• Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding  Academic Article
• Trends in Atrial Fibrillation Complicating Acute Myocardial Infarction  Academic Article
• Trends in Prescribing Oral Anticoagulants in Canada, 2008–2014  Academic Article
• Trends in incidence and prevalence of hospitalization for atrial fibrillation and associated mortality in Western Australia, 1995–2010  Academic Article
• Trifecta or Triple Threat? The Challenge of Post-PCI Management in Patients Receiving Chronic Oral Anticoagulant Therapy  Academic Article
• Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation  Academic Article
• Triple Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Stents  Academic Article
• Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF  Academic Article
• Type 2 Diabetes Mellitus and Risk of Incident Atrial Fibrillation in Women  Academic Article
• Uncertainty in the minimum event risk to justify treatment was evaluated  Academic Article
• Underpowered observational studies create confusion regarding clinical impact of surgical interventions  Academic Article
• Underuse of evidence-based warfarin dosing methods for atrial fibrillation patients  Academic Article
• Unmasking of the Brugada Syndrome Phenotype During the Acute Phase of Amiodarone Infusion  Academic Article
• Unresolved issues in anticoagulant therapy  Conference Paper
• Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review  Academic Article
• Use and Underuse of Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Old and New Paradigms  Academic Article
• Use of Evidence-Based Therapy for Cardiovascular Risk Factors in Canadian Outpatients With Atrial Fibrillation  Academic Article
• Use of Warfarin in People with Low Glomerular Filtration Rate or on Dialysis  Academic Article
• Use of warfarin (coumarin).  Academic Article
• Usefulness of propafenone for recurrent paroxysmal atrial fibrillation  Academic Article
• Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation  Academic Article
• Utility of B-Type Natriuretic Peptide (BNP) as a Screen for Left Ventricular Dysfunction in Patients With Diabetes  Academic Article
• Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation.  Academic Article
• Values and preferences for oral antithrombotic therapy in patients with atrial fibrillation: physician and patient perspectives  Academic Article
• Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study  Academic Article
• Variation in Warfarin Dose Adjustment Practice Is Responsible for Differences in the Quality of Anticoagulation Control Between Centers and Countries  Academic Article
• Variation in bleeding risk estimates among online calculators  Academic Article
• Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries  Academic Article
• Venice Chart International Consensus Document on Atrial Fibrillation Ablation: 2011 Update  Academic Article
• Verapamil and supraventricular tachyarrhythmias: beneficial effect in patients with chronic pulmonary disease.  Academic Article
• Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis  Conference Paper
• Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin  Academic Article
• Warfarin Interactions With Antibiotics in the Ambulatory Care Setting  Academic Article
• Warfarin Therapy for Atrial Fibrillation: The Patient's Preference Is Important  Academic Article
• Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility  Academic Article
• Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis  Academic Article
• Warfarin use in atrial fibrillation: A random sample survey of family physician beliefs and preferences.  Academic Article
• Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty  Academic Article
• Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden  Academic Article
• What Do Implanted Cardiac Monitors Reveal About Atrial Fibrillation?  Academic Article
• What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review  Academic Article
• What Is the Future of Factor XI Inhibitors?  Academic Article
• What is the role of growth-differentiation factor-15 in biomarker-based prediction of mortality in patients with atrial fibrillation?  Academic Article
• Which Patients With Atrial Fibrillation and Chronic Kidney Disease Should Receive Anticoagulation—And With Which Anticoagulant?  Academic Article
• Which Risk Factors Are More Associated With Ischemic Stroke Than Intracerebral Hemorrhage in Patients With Atrial Fibrillation?  Academic Article
• Whole Blood Gene Expression Differentiates between Atrial Fibrillation and Sinus Rhythm after Cardioversion  Academic Article
• Why Do Patients With Atrial Fibrillation Not Receive Warfarin?  Academic Article
• Why aren't we falling for anticoagulant therapy?  Academic Article
• World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update  Academic Article
• XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation  Academic Article
• XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation  Academic Article
• Ximelagatran in the Clinic: Practical Management of Patients  Academic Article
• Ximelagatran or Warfarin for Stroke Prevention in Patients With Atrial Fibrillation?  Academic Article
• Ximelagatran or warfarin in atrial fibrillation?  Academic Article
• [Antithrombotic treatment of atrial fibrillation].  Academic Article
• [Auricular fibrillation and flutter].  Academic Article
• ‘Real world’ use of non-vitamin K antagonist oral anticoagulants (NOACs): Lessons from the Dresden NOAC Registry  Academic Article